RxDoctor Payments Data

Amanda Smith

Family · Monticello, MSNPI 1992324834

Payments from drug & device makers

$376in general payments, 2019–2025

Across 22 payments — averaging $17.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$97
  • Organogenesis Inc.$64
  • Lilly USA, LLC$60
  • GSK$35
  • AstraZeneca$29
  • Merck$28
  • plus $63 from 4 others

What the payments were for

  • Food & beverage$376100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$376 in reported general payments places this provider in the 50th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$102,110
Medicare patients
350
Services billed
2,433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban37$26,412
OzempicSemaglutide15$18,978
XareltoRivaroxaban18$16,283
JanuviaSitagliptin Phosphate21$16,112
JardianceEmpagliflozin18$13,837
FarxigaDapagliflozin Propanediol23$13,438
MicafunginMicafungin Sodium15$6,798
Verapamil SrVerapamil Hcl17$2,391
LantusInsulin Glargine,hum.Rec.Anlog15$2,382
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$1,430
Potassium Chloride141$1,299
Levothyroxine Sodium206$1,132
Gabapentin148$1,120
Potassium Citrate ErPotassium Citrate13$1,111
Pantoprazole Sodium139$1,066

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$15$18,97815 claims
MerckJanuvia$28$16,11221 claims
Boehringer IngelheimJardiance$13$13,83718 claims
AstraZenecaFarxiga$29$13,43823 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,007 family providers in Mississippi.

Other family in Monticello

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →